Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Benzylpiperazine Ban Proposed in Europe
June 20, 2007

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

The European government is considering a ban on benzylpiperazine, a currently legal stimulant that is used as an alternative to drugs like ecstasy.

The Guardian reported June 18 that a report from Europol and the European Monitoring Center for Drugs and Drug Addiction called for a ban on the drug, also known as BZP and street names like Jax, Pep Twisted, and Pep Love.

"Users have reported a range of adverse reactions such as vomiting, headache, palpitations, poor appetite, stomach pains/nausea, anxiety, insomnia, strange thoughts, mood swings, confusion, irritability and tremors," the report noted. "Some of these occurred in the 'comedown' period, and some persisted for 24 hours after use."

BZP can be legally purchased in head shops and online. The European Commission will decide whether to adopt the report's recommendations in the next few weeks.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.